Connection

Antonio Giordano to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Antonio Giordano has written about Protein Kinase Inhibitors.
Antonio Giordano
Connection Strength
1.341
Protein Kinase Inhibitors
  1. Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. PLoS One. 2019; 14(11):e0224420.
    View in: PubMed
    Score: 0.559
  2. Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells. Cell Cycle. 2013 Sep 01; 12(17):2839-48.
    View in: PubMed
    Score: 0.362
  3. Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov. 2009 Jul; 8(7):547-66.
    View in: PubMed
    Score: 0.272
  4. Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines. Int J Mol Sci. 2020 Oct 04; 21(19).
    View in: PubMed
    Score: 0.148
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.